<VariationArchive VariationID="2445207" VariationName="NM_207346.3(TSEN54):c.953del (p.Pro318fs)" VariationType="Deletion" Accession="VCV002445207" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2023-03-26" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2418934" VariationID="2445207">
      <GeneList>
        <Gene Symbol="TSEN54" FullName="tRNA splicing endonuclease subunit 54" GeneID="283989" HGNC_ID="HGNC:27561" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75516528" stop="75524735" display_start="75516528" display_stop="75524735" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73512608" stop="73520819" display_start="73512608" display_stop="73520819" Strand="+" />
          </Location>
          <OMIM>608755</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_207346.3(TSEN54):c.953del (p.Pro318fs)</Name>
      <CanonicalSPDI>NC_000017.11:75522030:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="75522031" stop="75522031" display_start="75522031" display_stop="75522031" variantLength="1" positionVCF="75522030" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="73518112" stop="73518112" display_start="73518112" display_stop="73518112" variantLength="1" positionVCF="73518111" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>P318fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.73518115del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.73518115del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.75522034del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.75522034del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013041.1" sequenceAccession="NG_013041" sequenceVersion="1" change="g.10507del">
            <Expression>NG_013041.1:g.10507del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_207346.3" sequenceAccession="NM_207346" sequenceVersion="3" change="c.953del" MANESelect="true">
            <Expression>NM_207346.3:c.953del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_997229.2" sequenceAccession="NP_997229" sequenceVersion="2" change="p.Pro318fs">
            <Expression>NP_997229.2:p.Pro318fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_207346.3(TSEN54):c.953del (p.Pro318fs) AND multiple conditions" Accession="RCV003154618" Version="2">
        <ClassifiedConditionList TraitSetID="84383">
          <ClassifiedCondition DB="MedGen" ID="C1848552">Methylmalonic aciduria and homocystinuria type cblD</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1856974">Pontocerebellar hypoplasia type 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1857762">Pontocerebellar hypoplasia type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_207346.3(TSEN54):c.953del (p.Pro318fs) AND not provided" Accession="RCV003561198" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-03-26" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18711368</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20952379</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="84383" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="2914" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Methylmalonic acidemia with homocystinuria cblD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">METHYLMALONIC ACIDEMIA, cblH TYPE</ElementValue>
                <XRef Type="MIM" ID="277410" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Methylmalonic aciduria and homocystinuria type cblD</ElementValue>
                <XRef ID="MONDO:0010185" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria with homocystinuria cblD type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAHCD</ElementValue>
                <XRef Type="MIM" ID="277410" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3582" />
                <XRef ID="3582" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301409</ID>
                <ID Source="BookShelf">NBK1231</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="622" DB="Orphanet" />
              <XRef ID="79283" DB="Orphanet" />
              <XRef ID="C1848552" DB="MedGen" />
              <XRef ID="MONDO:0010185" DB="MONDO" />
              <XRef Type="MIM" ID="277410" DB="OMIM" />
            </Trait>
            <Trait ID="3365" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pontocerebellar hypoplasia type 4</ElementValue>
                <XRef ID="Pontocerebellar+hypoplasia+type+4/5866" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009166" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy fatal infantile with olivopontocerebellar hypoplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCH4</ElementValue>
                <XRef Type="MIM" ID="225753" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures ("arthrogryposis"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.</Attribute>
                <XRef ID="NBK9673" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="343" />
                <XRef ID="343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301773</ID>
                <ID Source="BookShelf">NBK9673</ID>
              </Citation>
              <XRef ID="166063" DB="Orphanet" />
              <XRef ID="C1856974" DB="MedGen" />
              <XRef ID="MONDO:0009166" DB="MONDO" />
              <XRef Type="MIM" ID="225753" DB="OMIM" />
            </Trait>
            <Trait ID="3520" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pontocerebellar hypoplasia type 5</ElementValue>
                <XRef ID="Pontocerebellar+hypoplasia+type+5/5867" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012438" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Olivopontocerebellar hypoplasia fetal-onset</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCH5</ElementValue>
                <XRef Type="MIM" ID="610204" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10709" />
                <XRef ID="10709" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings. The three PCH phenotypes (which differ mainly in life expectancy) were considered to be distinct entities before their molecular basis was known. PCH2. Children usually succumb before age ten years (those with PCH4 and 5 usually succumb as neonates). Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections. Epilepsy is present in approximately 50%. PCH4. Neonates often have seizures, multiple joint contractures ("arthrogryposis"), generalized clonus, and central respiratory impairment. PCH5 resembles PCH4 and has been described in one family.</Attribute>
                <XRef ID="NBK9673" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301773</ID>
                <ID Source="BookShelf">NBK9673</ID>
              </Citation>
              <XRef ID="166068" DB="Orphanet" />
              <XRef ID="C1857762" DB="MedGen" />
              <XRef ID="MONDO:0012438" DB="MONDO" />
              <XRef Type="MIM" ID="610204" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7179723" SubmissionDate="2023-02-24" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="PED7102.12|OMIM:610204;277410;225753" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003843207" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, UniversitÃ© de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was observed in compound heterozygosity with variant c.919G&gt;T</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-gen. Sequencing</TypePlatform>
              <Description>Exome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSEN54" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207346.2:c.953del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610204" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277410" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="225753" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12873630</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983178" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4945610|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297532" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18711368</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952379</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20952379</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro318Glnfs*24) in the TSEN54 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSEN54 are known to be pathogenic (PMID: 18711368, 20952379). This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with pontocerebellar hypoplasia (PMID: 20952379). ClinVar contains an entry for this variant (Variation ID: 2445207). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSEN54" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.73518112del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7983178" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7179723" TraitType="Disease" MappingType="XRef" MappingValue="610204" MappingRef="OMIM">
        <MedGen CUI="C1857762" Name="Pontocerebellar hypoplasia type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7179723" TraitType="Disease" MappingType="XRef" MappingValue="277410" MappingRef="OMIM">
        <MedGen CUI="C1848552" Name="Methylmalonic aciduria and homocystinuria type cblD" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7179723" TraitType="Disease" MappingType="XRef" MappingValue="225753" MappingRef="OMIM">
        <MedGen CUI="C1856974" Name="Pontocerebellar hypoplasia type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

